港股创新药ETF、港股创新药50ETF年内涨超110%，港股通互联网ETF、港股通创新药ETF 、恒生科技ETF强势吸金

Group 1 - The Hang Seng Index has risen over 30% this year, while the Hang Seng Tech Index has increased by more than 32% [1] - Hong Kong stocks are leading global markets, with significant capital inflow, totaling 1,038.994 billion yuan, with over 100 billion yuan invested in Alibaba, Meituan, and other major companies [2] - Alibaba's stock price has reached a new high, supported by the launch of the "Gao De Street Ranking" and a 1 billion yuan subsidy program to boost offline consumption [3] Group 2 - A total of 189.2 billion yuan has flowed into ETFs tracking Hong Kong stocks this year, with significant inflows into various sector-specific ETFs [4] - Ten ETFs have seen over 100% growth this year, particularly those focused on innovative pharmaceuticals and biotechnology [6] - The current market shows a strong performance in both Hong Kong and A-shares, with several ETFs doubling in value [5] Group 3 - Market activity is robust, but the Hang Seng Index is experiencing consolidation at high levels, with limited room for further valuation expansion in the short term [7] - The recovery in earnings expectations is supported by new economy sectors such as technology and healthcare, which now account for 70% of the MSCI China Index [8]